Cocaine misuse treatment in England

International Journal of Drug Policy

Volumn 11, Issue 3, 2000, Pages 203-215

  Seivewright, Nicholas ^a   Donmall, Michael ^b   Douglas, Julie ^b   Draycott, Tamara ^a   Millar, Tim ^b  

^a SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cocaine misuse; Effectiveness; Treatments

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; CHLORPROMAZINE; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; METHADONE; NITRAZEPAM; PAROXETINE; TEMAZEPAM; THIORIDAZINE; TRIFLUOPERAZINE;

ACUPUNCTURE; ADULT; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG MISUSE; FEMALE; HUMAN; INTERVIEW; MALE; MEDICAL STAFF; PATIENT COUNSELING; POLICY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REHABILITATION; REVIEW; SOCIAL PROBLEM; TREATMENT OUTCOME; UNITED KINGDOM; WITHDRAWAL SYNDROME;

EID: 0343962133     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(00)00045-1     Document Type: Review

References (48)

1. Advisory Council on the misuse of Drugs, 1988. AIDS and Drug Misuse, Part I HMSO, London.
2. Batki S.L., Manfredi L.B., Jacob P., Jones R.T. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J. Clin. Psychopharmacol. 13:1993;243-250.
3. Batki S.L., Washburn A.M., Delucchi K., Jones R.T. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol. Depend. 41:1996;137-142.
4. Bottomley T., Carnwath T., Jeacock J., Wibberley C., Smith M. Crack cocaine-tailoring services to user need. Addict. Res. 5:1997;223-234.
5. Covi L., Hess J.M., Kreiter N.A., Haertzen C.A. Effects of combined fluoxetine and counselling in the outpatient treatment of cocaine abusers. Am. J. Drug Alcohol Abuse. 21:1995;327-344.
6. Cregler L., Mark H. Medical complications of cocaine abuse. New Engl. J. Med. 315:1986;1495-1500.
7. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br. J. Addiction. 87:1992;733-742.
8. Darke S., Ross J., Cohen J. The use of benzodiazepines among regular amphetamine users. Adiction. 89:1994;1683-1690.
9. Department of Health, 1996. The Task Force to Review Services for Drug Misusers. Department of Health, Wetherby, UK.
10. Galanter M., Egelko S., Deleon G., Rohrs C., Franco H. Crack cocaine abusers in the general hospital: assessment an initiation of care. Am. J. Psychaitr. 149:1992;810-815.
11. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnoses in cocaine abusers:clinicalobservations. Arch. Gen. Psychiatr. 43:1986;107-113.
12. Goldstein P., Brownstein H., Ryan P., Bellucci P. Crack and homicide in New York City, 1988: a conceptually based event analysis. Contemp. Drug Problems. 16:1989;651-687.
13. Gossop, M., 1987. Beware cocaine. Br. Med. J. 295, 945.
14. Grabowski J., Rhoades H., Elk R., Schmitz J., Davis C., Creson D., Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J. Clin. Psychopharmacol. 15:1995;163-174.
15. Halkias J., Crosby R., Carlson G. Current pharmacotherapy practices for cocaine abuse. Annals. Clin. Psychiatr. 3:1991;167-168.
16. Halkias J.A., Kuhn K.L., Crea F.S., Carlson G.A., Crosby R. Treatment of crack cocaine use with carbamazepine. Am. J. Drug Alcohol Abuse. 18:1992;45-56.
17. Hando J., Flaherty B., Rutter S. An Australian profile on the use of cocaine. Addiction. 92:1997;173-182.
18. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatr. 51:1994;568-576.
19. Hulse G.K., Milne G., English D.R., Holman C.D.J. Assessing the relationship between maternal cocaine misuse and abruptio placentae. Addiction. 92:1997;1547-1551.
20. Hunter G.M., Donoghoe M.C., Stimson G.V. Crack use and injection on the increase among injecting drug users in London. Addiction. 90:1995;1397-1400.
21. Johnson EM Cocaine: the American experience. Allen D. The Cocaine Crisis. 1987;Plenum, New York.
22. Kain Z.N., Kain T.S., Scarpelli E.M. Cocaine exposure in utero: perinatal development and neonatal manifestations-review. Clin. Toxicol. 30:1992;607-636.
23. Levin F.R., Lehman A.F. Meta-anaylsis of desipramine as an adjunct in the treatment of cocaine addiction. J. Clin. Psychopharmacol. 11:1991;374-378.
24. Lipton D.S., Brewington V., Smith M. Acupuncture for crack-cocaine detoxification: experimental evaluation of efficacy. J. Substance Abuse Treat. 11:1994;205-215.
25. Marsden J., Griffiths P., Farrell M., Gossop M., Strang J. Cocaine in Britain: prevalence, problems and treatment responses. J. Drug Issues. 28:1998;225-242.
26. Mendoza R., Miller B. Neuropsychiatric disorders associated with cocaine use. Hospital Community Psychiatr. 43:1992;677-680.
27. Monti P.M., Rohsenow D.J., Michalec E., Martin R.A., Abrams D.B. Brief coping skills tratment for cocaine abuse: substance use outcomes at three months. Addiction. 92:1997;1717-1728.
28. Nathan K.I., Bresnick W.H., Batki S.L. Cocaine abuse and dependence. Approaches to management CNS. Drugs. 10:1998;43-59.
29. National Institute of Drug Abuse, 1985. National Household Survey. NIDA, Rockville, MD.
30. O'Brien C.P., Childress A.P., McLellan T. et al. Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. Addict. Behav. 15:1990;355-365.
31. Pickering H., Stimson G.V. Prevalence and demographic factors of stimulant use. Addiction. 89:1994;1385-1389.
32. Pollock M., Brotman A., Rosenbaum J. Cocaine abuse and treatment. Compr. Psychiatr. 30:1989;31-44.
33. Polson R.G., Fleming P.M., O'Shea J.K. Fluoxetine in the treatment of amphetamine dependence. Hum. Psychopharmacol. 8:1993;55-58.
34. Rawson R.A., McCann M.J., Hasson A.J., Ling W. Cocaine abuse among methadone maintenance patients: are there effective treatment strategies? J. Psychoact. Drugs. 26:1994;129-136.
35. Rawson R.A., Obert J., McCann M.J., Castro F.G., Ling W. Cocaine abuse treatment: a review of current strategies. J. Subst. Abuse. 3:1991;457-491.
36. Resnick R.B., Resnick E.B. Cocaine abuse and its treatment. Psychiatr. Clin. N. Am. 7:1984;713-728.
37. Seivewright N. Theory and practice in managing benzodiazepine dependence and abuse. J. Subst. Misuse. 3:1998;170-177.
38. Sellers E.M., Higgins G.A., Tomkins D.M. et al. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. J. Clin. Psychiatr. 12 (suppl) 52:1991;49-54.
39. Silverman K., Higgins S.T., Brooner R.K., Montoya I.D., Cone E.J., Schuster C.R., Preston K.L. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatr. 53:1996;409-415.
40. Standing Conference on Drug Abuse, 1992. Drug problems: Where to get help. SCODA, London.
41. Strang J., Edwards G. Cocaine and crack. Br. Med. J. 299:1989;337-338.
42. Strang J, Gossop M Heroin Addiction and Drug Policy. 1994;Oxford University Press, Oxford.
43. Strang J., Griffiths P., Gossop M. Crack and cocaine use in South London drug addicts: 1987-1989. Br. J. Addict. 85:1990;193-196.
44. Strang J., Johns A., Caan W. Cocaine in the UK, 1991. Br. J. Psychiatr. 162:1993;1-13.
45. Warner E.A., Kosten T.R., O'Connor P.G. Pharmacotherapy for opioid and cocaine abuse. Med. Clin. North. Am. 81:1997;909-925.
46. Weddington W.W., Brown B.S., Haertzen C.A., Cone E.J., Dax E.M., Herning R.I., Michaelson B.S. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch. Gen. Psychiatr. 47:1990;861-868.
47. Withers N.W., Pulvirenti L., Koob G.F., Gillin J.C. Cocaine abuse and dependence. J. Clin. Psychopharmacol. 15:1995;63-78.
48. Zweben J.E. Recovery-orientated psychotherapy. J. Subst. Abuse. Treat. 3:1986;255-262.